Therapeutic Targets in Chronic Lymphocytic Leukemia

被引：3
|
作者：
Laurenti, Luca [1 ]
Efremov, Dimitar G. [2 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dept Hematol, I-00168 Rome, Italy
[2] Int Ctr Genet Engn & Biotechnol, Mol Hematol, I-34149 Trieste, Italy
来源：
CANCERS | 2020年 / 12卷 / 11期
关键词：
IBRUTINIB RESISTANCE; CLONAL EVOLUTION; DE-NOVO; VENETOCLAX; CLL; DISEASE; BTK; INHIBITION;
D O I：
10.3390/cancers12113259
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Updates in the management of chronic lymphocytic leukemia/small lymphocytic leukemia
    Hanna, Kirollos S.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (01) : 146 - 155
  • [22] Integrating New Therapies for Chronic Lymphocytic Leukemia
    Burger, Jan A.
    CANCER JOURNAL, 2021, 27 (04) : 275 - 285
  • [23] Pharmacotherapy of relapsed/refractory chronic lymphocytic leukemia
    Abou Zahr, Abdallah
    Bose, Prithviraj
    Keating, Michael J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (09) : 857 - 873
  • [24] Novel molecular diagnostic and therapeutic targets in chronic lymphocytic leukaemia
    Gaiger, A
    Heintel, D
    Jäger, U
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2004, 34 : 25 - 30
  • [25] Venetoclax as a therapeutic option for the treatment of chronic lymphocytic leukemia: the evidence so far
    Held, Lauren
    Siu, Chloe
    Shadman, Mazyar
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (06) : 655 - 665
  • [26] Genetics of Chronic Lymphocytic Leukemia
    Schnaiter, Andrea
    Mertens, Daniel
    Stilgenbauer, Stephan
    CLINICS IN LABORATORY MEDICINE, 2011, 31 (04) : 649 - +
  • [27] Retreatment with obinutuzumab: An addition to the therapeutic landscape of chronic lymphocytic leukemia
    Khurana, Sharad
    Ahmed, Salman
    Alegria, Victoria R.
    Aulakh, Sonikpreet
    Ailawadhi, Meghna
    Singh, Anshika
    Chanan-Khan, Asher
    Ailawadhi, Sikander
    SAGE OPEN MEDICAL CASE REPORTS, 2019, 7
  • [28] Cell Penetrating Peptides as a Therapeutic Strategy in Chronic Lymphocytic Leukemia
    Arrouss, Issam
    Decaudin, Didier
    Choquet, Sylvain
    Azar, Nabih
    Parizot, Christophe
    Zini, Jean M.
    Nemati, Fariba
    Rebollo, Angelita
    PROTEIN AND PEPTIDE LETTERS, 2015, 22 (06) : 539 - 546
  • [29] Resistance mechanisms and approach to chronic lymphocytic leukemia after BTK inhibitor therapy
    Gruessner, Christine
    Wiestner, Adrian
    Sun, Clare
    LEUKEMIA & LYMPHOMA, 2025,
  • [30] Targeting the microenvironment in chronic lymphocytic leukemia is changing the therapeutic landscape
    Burger, Jan A.
    CURRENT OPINION IN ONCOLOGY, 2012, 24 (06) : 643 - 649
12345